BIOX vs SNES

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Nov 15, 2026

BIOX

60.3
AI Score
VS
BIOX Wins

SNES

28.9
AI Score

Investment Advisor Scores

BIOX

60score
Recommendation
HOLD

SNES

29score
Recommendation
AVOID NEW MONEY

AI Analyst Insights

Detailed Metrics Comparison

Metric BIOX SNES Winner
Forward P/E 14.9925 3.399 SNES
PEG Ratio 1.9521 -0.06 Tie
Revenue Growth -23.4% 59.0% SNES
Earnings Growth 34.4% 0.0% BIOX
Tradestie Score 60.3/100 28.9/100 BIOX
Profit Margin -108.5% -275.3% BIOX
Beta 1.00 1.00 Tie
AI Recommendation HOLD AVOID NEW MONEY BIOX

Relative Price Performance (Last 90 Days)

BIOX 1M: -28.6% · 3M: -52.0% SNES 1M: +23.3% · 3M: -28.8%

Current Technical Phase

BIOX

Markdown
Sell / avoid

Price below a falling SMA50 (slope -19.1%), weak momentum, RSI 39

RSI (14): 39.2 · Price: $0.21

SNES

Distribution
Trim / tighten stop

Price near a flattening SMA50 (slope -10.1%) with fading momentum, RSI 45

RSI (14): 44.7 · Price: $0.86

Fundamentals Snapshot

Metric BIOX SNES
Market Cap — —
Forward P/E 4.2 -0.8
Trailing P/E — —
Revenue (TTM) — —
Revenue Growth -0.2% 0.6%
Gross Margin 0.3% 0.7%
Operating Margin 0.0% -2.8%
EPS -1.20 -1.30
Dividend Yield — —

Frequently Asked Questions

Based on our detailed analysis, BIOX is currently the stronger investment candidate based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.